Long-Term Outcome of Adult Congenital Heart Disease Patients with Implantable Cardioverter-Defibrillators
Mai Ishiwata1,2, Kohei Ishibashi1,*, Yoshiaki Kato3, Heima Sakaguchi3, Toshihiro Nakamura1, Satoshi Oka1, Yuichiro Miyazaki1, Akinori Wakamiya1, Nobuhiko Ueda1, Kenzaburo Nakajima1, Tsukasa Kamakura1, Mitsuru Wada1, Yuko Inoue1, Koji Miyamoto1, Takeshi Aiba1, Norihiko Takeda2, Kengo Kusano1
Congenital Heart Disease, Vol.20, No.3, pp. 273-286, 2025, DOI:10.32604/chd.2025.067716
- 11 July 2025
Abstract Background: Ventricular arrhythmia is a common cause of mortality in adult congenital heart disease (ACHD). The beneficial effects of implantable cardioverter-defibrillators (ICD) in patients with ACHD have been demonstrated; however, evidence on this topic remains insufficient. This study aimed to assess the long-term outcomes after ICD implantation in the ACHD population. Methods: We retrospectively reviewed 35 consecutive patients with ACHD who underwent ICD implantation between December 2012 and August 2022. ICD implantation was classified as primary or secondary prevention. The long-term outcomes, including all-cause mortality, appropriate and inappropriate ICD therapy, and complications related to ICD implantation, were… More >
Graphic Abstract